Celcuity Inc.

10/10/2022 | Press release | Archived content

Bis(morpholino 1,3,5 triazine) Derivatives: Potent Adenosine 50 Triphosphate Competitive Phosphatidylinositol 3 kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of[...]